The Association for Professionals in Infection Control and Epidemiology (APIC) is the leading professional association for infection preventionists (IPs) with more than 15,000 members. Our mission is to create a safer world through the prevention of infection. This is achieved by the provision of better care to promote better health at a lower cost.
Most APIC members are nurses, physicians, public health professionals, epidemiologists, microbiologists, or medical technologists who:
Collect, analyze, and interpret health data in order to track infection trends, plan appropriate interventions, measure success, and report relevant data to public health agencies.
Establish scientifically based infection prevention practices and collaborate with the healthcare team to assure implementation.
Work to prevent healthcare-associated infections (HAIs) in healthcare facilities by isolating sources of infections and limiting their transmission.
Educate healthcare personnel and the public about infectious diseases and how to limit their spread.
Many IPs are employed within healthcare institutions and also serve as educators, researchers, consultants, and clinical scientists. The majority of APIC members are affiliated with acute care settings. An increasing number practice in ambulatory and outpatient services where they direct programs that protect patients and personnel from HAIs. Members are also involved in long-term care, home health, and other practice settings where infection prevention and control is an increasing area of responsibility for nurses and other healthcare personnel.
The Center for Disease Control and Prevention Division of Viral Hepatitis posts valuable viral hepatitis information. Following is its post commemorating World Hepatitis Day. Visit the CDC’s viral hepatitis webpage for more viral hepatitis information.
Know Hepatitis. Act Now. For World Hepatitis Day, learn more about the different types of viral hepatitis that impact millions worldwide, and what you can do.
Viral hepatitis – a group of infectious diseases known as hepatitis A, B, C, D, and E- affects almost 400 million people worldwide, causing both acute (short-term) and chronic (long-term) liver disease and killing more than 1.4 million people every year. In 2013, viral hepatitis was the seventh leading cause of death worldwide, compared with the tenth in 1990, and caused more deaths than AIDS, tuberculosis, and even road injuries. World Hepatitis Day is July 28th and is an opportunity to highlight the global burden of this disease, CDC’s efforts to combat viral hepatitis around the world, and what actions individuals can take.
What is CDC doing to help combat hepatitis globally?
The vision of CDC is to eliminate viral hepatitis in the United States and worldwide. CDC’s recently released five-year strategic plan[PDF – 17 pages] is organized around four key elements, one of which is “Act globally to prevent, detect, and control viral hepatitis.”
CDC has been re-designated as a Pan American Health Organization/World Health Organization (PAHO/WHO) Collaborating Center for Reference and Research on Viral Hepatitis. These WHO Collaborating Centers work to implement WHO’s Global Hepatitis Strategy priority activities, serving as a reference laboratory, and providing technical assistance for the development of viral hepatitis guidelines and policies.
CDC also assists countries experiencing a high burden of viral hepatitis. In recent years, these countries have included China, Egypt, Georgia, India, Pakistan, and Vietnam. Our international work is helping to reduce the disease burden for travelers and people migrating to the United States, while identifying best practices that may serve as models for other countries, including the United States.
What are the different types of hepatitis viruses occurring around the world?
The five hepatitis viruses – A, B, C, D and E – are distinct; they can have different modes of transmission, affect different populations, and result in different health outcomes. While hepatitis B and hepatitis C cause the greatest global burden of disease, hepatitis A, hepatitis D, and hepatitis E are also global health concerns.
Hepatitis A is primarily spread when someone who has never been infected with hepatitis A and is not vaccinated, ingests food or water that is contaminated with the feces of an infected person or has direct contact with someone who is infected. Hepatitis A does not cause chronic liver disease and is rarely fatal, but it can cause serious symptoms. Hepatitis A can be prevented through improved sanitation, food safety, and vaccination.
Hepatitis B is spread through contact with blood or other body fluids of an infected person, including at birth from a mother to her baby and through sexual contact. The hepatitis B virus can cause both acute and chronic infection, ranging in severity from a mild illness lasting a few weeks to a serious, chronic illness. People who are chronically infected can develop liver cirrhosis or even liver cancer. Hepatitis B is most common in sub-Saharan Africa and east Asia, where between 5–10% of the adult population is chronically infected. Rates of chronic hepatitis B are also high in the Amazon region of South America, the southern parts of eastern and central Europe, the Middle East and the Indian subcontinent. Many people with chronic hepatitis B were infected at birth or during early childhood. Getting the hepatitis B vaccine is the most effective way to prevent hepatitis B virus infection. WHO recommends that all infants receive the hepatitis B vaccine as soon as possible after birth. In many parts of the world, widespread infant vaccination programs have led to dramatic declines of new hepatitis B cases.
Hepatitis C is spread through contact with blood of an infected person. Hepatitis C is common in many countries in the world; in much of Asia and Africa, most infections are caused by unsafe medical injections and other medical procedures. Hepatitis C related to injecting drug use occurs throughout the world; an estimated 67% of people who inject drugs having been infected with the hepatitis C virus. Mother-to-child transmission of hepatitis C is also possible. Hepatitis C, like hepatitis B, can also cause both acute and chronic infections, but most people who get infected develop a chronic infection. A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer. Antiviral medicines can cure approximately 90% of people with hepatitis C, thereby reducing the risk of death from liver cancer and cirrhosis, but access to diagnosis and treatment is low. There is currently no vaccine for hepatitis C but research in this area is ongoing.
Hepatitis D is passed through contact with infected blood. It only occurs in people who are already infected with the hepatitis B virus. People who are not already infected with hepatitis B can prevent hepatitis D by getting vaccinated against hepatitis B.
Hepatitis E is spread mainly through contaminated drinking water. Hepatitis E usually clears in 4-6 weeks so there is no specific treatment. However, pregnant women infected with hepatitis E are at considerable risk of mortality from this infection. Hepatitis E is found worldwide, but the number of infections is highest in East and South Asia. Improved sanitation and food safety can help prevent new cases of hepatitis E. A vaccine to prevent hepatitis E has been developed and is licensed in China, but is not yet available elsewhere.
Do you need to be vaccinated and/or tested for hepatitis?
CDC and DVH are continuing to lay the foundation for the elimination of viral hepatitis as a public health threat, both domestically and abroad. Hepatitis A, hepatitis B, and hepatitis C are the most common types of viral hepatitis in the United States. To see if you need to be tested and/or vaccinated for hepatitis A, B, or C, take CDC’s online Hepatitis Risk Assessment, which is based on U.S. recommendations.
As we commemorate World Hepatitis Day, we remember that unsafe infections transmit infections. We are grateful to the World Health Organization for its efforts in preventing viral hepatitis globally. Many cases of viral hepatitis are transmitted by unsafe injections. Following is a poster to guide healthcare providers in administering safe injections.
The World Health Organization reminds us that we need to make smart injection choices. Following are the questions that the WHO suggests we ask our healthcare provider before we receive an injection to help us make smart injection choices. Unsafe injections spread diseases such as viral hepatitis. When we communicate with our healthcare providers we make good decisions and healthcare improves.
World Hepatitis Day is later this week, but it is not too early to prepare! This week we will be sharing information about these deadly diseases and how to prevent them.
Today we are sharing an infographic prepared by the World Hepatitis Alliance on the number of cases, causes and cures of Hepatitis B and C. Did you know that the mortality rate has increased by 22% since 2000?
Please take a look at the infographic and share with your networks. Watch for more information this week. But most importantly, do what you can to eliminate hepatitis!
Healthcare providers in all types of settings have reviewed and followed safe medical injection best practices. Nonetheless, contamination—the “unthinkable”—still happens.
The CDC estimates that there have been more than 50 outbreaks of Hepatitis C and/or Hepatitis B in the past decade due to reused needles, syringes or medication vials.*
In 2000-2001 a cancer clinic in Fremont, Nebraska caused the worst hepatitis outbreak in US history. During chemotherapy treatments, 857 patients who were already waging the fights of their lives against cancer, were inexplicably exposed to the deadly, blood-borne hepatitis C virus. At least ninety-nine of them contracted the lethal illness. The horror was unprecedented—this was the largest healthcare-transmitted outbreak of hepatitis C in American history.
The program is delivered by myself and my husband, Tom McKnight, a family physician who helped uncover the Nebraska outbreak. It outlines our own story of infection attributed to reuse of syringes in a medical setting. We also examine factors contributing to the Fremont outbreak and make recommendations for prevention.
The continuing education presentation is offered at low or no cost to organizations sponsoring continuing education activities for healthcare professionals or consumer-focused activities.
This work began as a response to an unthinkable, preventable tragedy. By building safeguards into the injection process, incentivizing health care providers at all levels to universally follow fundamental safety standards, and educating and reeducating providers, all patients will be protected all the time. Future tragedies can be avoided.
Thank you for your interest in the work of HONOReform – the only organization dedicated to advancing injection safety. I am asking today for your support of our life-saving work.
Why do we advocate for injection safety?
You will be interested in this story about what happened in my family practice clinic recently that illustrates why we must – together – continue educating healthcare providers and patients about the critical need for injection safety.
My clinic scheduled an assessment by the CDC Nebraska Infection Control Assessment program team. These hard-working nurses and infection preventionists spent a day assessing our clinic’s policies and procedures, making sure that we are doing everything we can to prevent our patients from contracting disease while in our office.
At the end of the day, the assessment team sat down with us to give us their report. Fortunately, we are doing most things right.
But there was one thing that needed improvement. The team found an opened, unlabeled vial of lidocaine in a patient care area. Since the vial had not been disposed of properly, there was a risk that it could be reused improperly, potentially spreading disease.
How do we advance injection safety?
You probaby know that my wife contracted Hepatitis C through unsafe injection practices sixteen years ago. Since then, it is my personal crusade to educate about injection safety. I preach to doctors, nurses and medical students that it is never okay to reuse syringes, needles, medication vials or other medical equipment intended for one time use. But despite my efforts, an unsafe injection could have taken place, even in my own office. In 2016, HONOReform gave educational presentations to 2208 people as well as reaching thousands through social media and virtual audiences. Everyone who has been touched by the retelling of our story joins me in thanking you for your generous partnership and support. We are committed to educating about and advocating for injection safety with every possible opportunity, to keep you and your family safe when you access healthcare.
But even with all our efforts to educate about injection safety, there were eight outbreak investigations of disease transmission through unsafe injection practices in 2016, affecting thousands of Americans! Together we must work even harder to advance injection safety.
Here is how you can spread the word about injection safety
Talk to your healthcare providers about how they are keeping you safe through careful adherence to injection safety guidelines. Pass along HONOReform’s eagerness to provider a quality educational presentation to their professional organization. Here is a useful link: HONOReform’s educational presentation program.
Today I am asking for your support for HONOReform. Your contributions enable HONOReform to educate about the absoulte necessity of injection safety to keep healthcare safe for thousands. Click this “Help Save Lives” link to reach our website to make your gift.
Thank you for your consideration. I hope to hear from you soon.
Thomas A. McKnight, MD
PS Thanks for helping with this important need. Please donate today to help with our educational efforts.
Today we share information about immunizations for children, especially viral hepatitis immunization. We are grateful to Carrington College for developing the infographic about immunizations for children.
A deadly infection of the liver, hepatitis can eventually lead to cirrhosis, liver cancer, and other dangerous conditions. Viral hepatitis Immunization is available for some types of hepatitis, but not for all.
Typically spread by close personal contact, hepatitis A does not result in chronic infection. However, its symptoms can be quite severe, so early vaccination is important. As laid out below in the child immunization guide created by Carrington College, children between 12 and 23 months old receive multiple doses of the vaccine, with doses separated by at least 6 months.
The symptoms for hepatitis B are virtually identical to those associated with hepatitis A. Unfortunately, hepatitis B can also lead to chronic suffering. According to the recommended childhood vaccination schedule, the first dose of the hepatitis B vaccine is typically administered within 24 hours of a child’s birth. Further doses will be giver over the next 18 months.
There is currently no vaccine available for hepatitis C, although researchers are working hard to change that – possibly in conjunction with an HIV/AIDS vaccine. Full prevention is not possible without a vaccine, but experts at WebMD advise that those worried about contracting the disease avoid direct exposure to blood, practice safe sex, and not share needles with others.
Prevention is important for all types of diseases, especially for infections like hepatitis that can cause years of discomfort. Children and young adults can secure adequate protection through immunization. While injection safety is a concern as hepatitis shots can spread bloodborne diseases, the recent adoption of smart syringes (with features that prevent re-use) promises to reduce the risk of vaccine-related infection.
All of us have had experience with the flu – body aches, fever, headache, fatigue, sore throat and runny nose and disruption to normal life. Having the flu can result in a personal minor annoyance or in a major health crisis. The CDC urges everyone six months old and older to receive a yearly flu vaccination. But where should you get your flu shot? There are many places to get your flu shot, ranging from your personal physician’s office to “pop-up” flu shot clinics in public places such as airports and hospitals. Make sure that that the flu shot clinic adheres to injection safety standards. Ask if the organization that is providing the flu shot has taken the pledge for vaccination clinics. Share this checklist of best practices for vaccination clinics with your flu shot providers.